AGILE (Early Phase Platform Trial for COVID-19)

NCT04746183 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: CST-2: EIDD-2801
DRUG: CST-2: Placebo
DRUG: Nitazoxanide
DRUG: VIR-7832
DRUG: VIR-7831
DRUG: CST-5: Placebo
DRUG: Favipiravir
DRUG: Molnupiravir
DRUG: Paxlovid
DRUG: ALG-097558
DRUG: ALG-097558 and Remdesivir
DRUG: NHS standard of care as per COVID-19 treatment guidelines
DRUG: ALG-097558
DRUG: Placebo

Sponsor

University of Liverpool

Collaborators

[object Object]
[object Object]
[object Object]